GlassScriptPhysician profile
Pooja Uppalapati
NPI 1447754056
$523.14
in general payments reported to CMS, 2019-2025
8 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $35.19 · 2024: $139 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $174.49 | 2024-2025 | Acessa Provu System, Myosure Tissue Removal Device, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $146.88 | 2023-2025 | Myfembree, Gemtesa |
| Astrazeneca Pharmaceuticals LP | $60.67 | 2025 | Tezspire, Fasenra |
| Mimedx Group, INC. | $52.72 | 2025 | |
| Medtronic, INC. | $27.70 | 2024 | Sonicision |
| Meditrina | $22.71 | 2024 | |
| Merck Sharp & Dohme LLC | $20.05 | 2025 | Capvaxive, Gardasil 9 |
| Exact Sciences Corporation | $17.92 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Uppalapati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.